Ferdinand Paul Brandl

Title: Ferdinand Paul Brandl: Innovator in Pharmaceutical Terpolymers

Introduction

Ferdinand Paul Brandl is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals through his innovative work on terpolymers. His research focuses on enhancing the stability and effectiveness of pharmaceutical dosage forms.

Latest Patents

Brandl holds a patent for "Terpolymers and their use in pharmaceutical dosage forms." This patent describes a terpolymer composition where 20 to 35% by weight of the structural units are derived from acrylic acid, 45 to 60% from a hydrophobic methacrylate, and 15 to 40% from a third olefinic monomer. The terpolymers serve as crystallization inhibitors, preventing the recrystallization of active ingredients in an aqueous environment within the human or animal body.

Career Highlights

Ferdinand Paul Brandl is associated with BASF SE Corporation, a leading chemical company known for its innovative solutions. His work has contributed to advancements in pharmaceutical formulations, particularly in improving the delivery and stability of medications.

Collaborations

Brandl has collaborated with notable colleagues such as Theo Smit and Felicitas Guth. Their combined expertise has furthered research and development in the field of pharmaceutical sciences.

Conclusion

Ferdinand Paul Brandl's contributions to the development of terpolymers highlight his role as an innovator in the pharmaceutical industry. His work continues to influence the formulation of effective and stable medications.